Collaborative research presents special problems for patent seekers.
作者信息
Thorne Leigh W, Ergenzinger Edward R, Spruill W Murray
机构信息
Alston & Bird LLP, 3201 Beechleaf Court, Suite 600, Raleigh, North Carolina 27604, USA.
出版信息
Nat Biotechnol. 2004 Jul;22(7):901-2. doi: 10.1038/nbt0704-901.
PMID:15229550
Abstract
摘要
相似文献
1
Collaborative research presents special problems for patent seekers.
Nat Biotechnol. 2004 Jul;22(7):901-2. doi: 10.1038/nbt0704-901.
2
Research tool patents: tips for facing a "pay up now or litigate" ultimatum.
Nat Biotechnol. 2001 Nov;19(11):1075-7. doi: 10.1038/nbt1101-1075.
3
Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law.
Nat Biotechnol. 2003 Jan;21(1):97-9. doi: 10.1038/nbt0103-97.
4
Science and the law. Working through the patent problem.
Science. 2003 Feb 14;299(5609):1021. doi: 10.1126/science.299.5609.1021.
5
"Obvious to try": a proper patentability standard in the pharmaceutical arts?
Fordham Law Rev. 2008 Apr;76(5):2625-68.
6
US patent office, interfering again.
Nat Rev Drug Discov. 2002 Oct;1(10):750. doi: 10.1038/nrd936.
7
Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
Seton Hall Law Rev. 2012;42(3):1287-36.
8
A guide to drug discovery. Protecting your inventions: the patent system.
Nat Rev Drug Discov. 2003 Oct;2(10):823-30. doi: 10.1038/nrd1200.
9
Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
Future Med Chem. 2010 Jan;2(1):7-9. doi: 10.4155/fmc.09.126.
10
Patent first, ask questions later: morality and biotechnology in patent law.
William Mary Law Rev. 2003 Dec;45(2):469-547.
Zotero 插件